DG Capital's DG Value Funds declined 2.7% in the third quarter as smaller capitalization and distressed assets struggled. Year to date, the three DG Value Funds are up 6.49%, 5.42% and 5.76%.
Q3 2019 hedge fund letters, conferences and more
New position in BioDelivery Sciences International
In his third-quarter letter to investors, which was reviewed by ValueWalk, Dov Gertzulin said he added BioDelivery Sciences International stock to the fund's portfolio during the third quarter. The stock was a positive contributor to the fund's performance during the third quarter, and he expects it to continue...